Rare diseases
Investigational molecules
Locations
852 Winter Street, 02451-1439, United States
Mural Oncology Inc. is involved in clinical research for advanced cutaneous melanoma and advanced mucosal melanoma, with a therapeutic focus on immuno-oncology approaches centered on nemvaleukin alfa and its use alone or with pembrolizumab.
The sponsor’s melanoma portfolio reflects interest in tumor response assessment and immune-based cancer treatment for difficult-to-treat melanoma subtypes.
Mural Oncology Inc. runs clinical trials in conditions such as Fallopian tube cancer, Ovarian cancer, Peritoneal cancer index, Metastatic malignant melanoma, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Austria
ItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
